Assenagon Asset Management S.A. increased its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 211.7% in the first quarter, HoldingsChannel reports. The firm owned 215,890 shares of the biopharmaceutical company’s stock after b…